Camurus AB (publ) (STO:CAMX)
Sweden · Delayed Price · Currency is SEK 448.00
+10.60 (2.42%)
Mar 25, 2026, 3:19 PM CET
Camurus AB Market Cap
Camurus AB has a market cap or net worth of 26.13 billion as of March 25, 2026. Its market cap has decreased by -27.71% in one year.
Market Cap
26.13B
Enterprise Value
22.51B
Revenue
2.27B
Ranking
n/a
PE Ratio
35.68
Stock Price
448.00
Market Cap Chart
Since December 3, 2015, Camurus AB's market cap has increased from 1.66B to 26.13B, an increase of 1,470.79%. That is a compound annual growth rate of 30.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 26.13B | -28.86% |
| Dec 30, 2025 | 36.74B | 10.34% |
| Dec 30, 2024 | 33.30B | 11.26% |
| Dec 29, 2023 | 29.93B | 113.76% |
| Dec 30, 2022 | 14.00B | 69.32% |
| Dec 30, 2021 | 8.27B | -18.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioArctic AB | 27.15B |
| Hansa Biopharma AB | 2.99B |
| Flerie AB | 2.76B |
| Vicore Pharma Holding AB | 2.67B |
| Saniona AB | 2.08B |
| Egetis Therapeutics AB | 1.97B |
| Diamyd Medical AB | 1.87B |
| BioInvent International AB | 1.43B |